Dmitry A. Stetsenko

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Panel-Wide Screening of Tumour Cells of Diverse Histogenesis for Responsiveness to Silencing of miR-21, miR-17, and miR-155 by Mesyl Phosphoramidate Antisense Oligonucleotides2026
• Author response for "Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in BTK/Tec double deficient X-linked agammaglobulinemia model"2025
• Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in BTK / Tec double deficient X-linked agammaglobulinemia model2025
• Synthesis of New Polyfluoro Oligonucleotides via Staudinger Reaction2024
• Primary screening of chemically modified immunosuppressive oligonucleotides using in vitro model with spleen lymphocytes2024
• Chemistry of Peptide-Oligonucleotide Conjugates: A Review2021
• Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties2019 · аннотациясвернуть

  Here we describe a DNA analog in which the mesyl (methanesulfonyl) phosphoramidate group is substituted for the natural phosphodiester group at each internucleotidic position. The oligomers show significant advantages…

• DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes2015 · аннотациясвернуть

  INTRODUCTION: Ongoing studies on the inhibition of gene expression at the mRNA level have identified several types of specific inhibitors such as antisense oligonucleotides, small interfering RNA, ribozymes and DNAzymes…